HYTRIN BPH cpr 5 mg 20 pce

7680523420238 CH-52342 G04CA03 05.99.0.
HYTRIN BPH cpr 5 mg 20 pce
HYTRIN BPH cpr 5 mg 20 pce
1 / 2
google

Details

Product number
5234203
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
terazosinum 5 mg ut terazosini hydrochloridum, lactosum monohydricum 123.07 mg, maydis amylum, talcum purificatum, magnesii stearas, E 172, pro compresso.

Articles (1)

Hytrin BPH 5 mg, Tabletten
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
19/01/2024
Patient information leaflet
Français
19/01/2024
Patient information leaflet
Italien
19/01/2024
Professional SmPC
Allemand
19/01/2024
Professional SmPC
Français
19/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
123.07 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 15.40
Specialties list
Yes
Generic
No
SL addition date: 15/03/1996

Authorization holder

Advanz Pharma Specialty Medicine

8048 Zürich

Authorization information

Swissmedic authorization number
52342
Drug name
Hytrin BPH, Tabletten
Galenic form
TAB
ATC Code
G04CA03
Authorization status
Z
Dispensation category
B
First authorization
21/10/1994
Authorization expiration date
31/12/9999
IT number
05.99.0.
Domain
Human medicine
Field of application
Benigne Prostatahyperplasie

Packaging details

Description (FR)
HYTRIN BPH cpr 5 mg 20 pce
Description (DE)
HYTRIN BPH Tabl 5 mg 20 Stk
Market launch
21/10/1994
Narcotic (BTM)
No

Other packaging sizes

HYTRIN BPH emballage départ cpr 7x1mg 7x2mg 14 pce
1 SET
View
HYTRIN BPH cpr 5 mg 60 pce
60 TABL
View